Publishing Research, Influencing Practice

Blood and Blood Advances continued to publish top quality, high-impact hematology research in 2023, with 1,648 manuscripts. The Blood journals family grew with Blood Vessels, Thrombosis & Hemostasis (VTH) and Blood Neoplasia announced in 2023.

 

The Hematologist celebrated 20 years of publication with the launch of a recurring “Now and Then” series that provided updates on articles published in its inaugural year. Fifteen new podcast episodes were released, with discussions ranging from an introduction with the new editors-in-chief of Blood VTH and Blood Neoplasia to the management of diffuse large B-cell lymphoma.

Jonathan Licht, MD
Editor-in-Chief of Blood Neoplasia
University of Florida Health Cancer Center

“I’ve worn many hats throughout my career as both a researcher and a practicing oncologist, which is why I aim to publish exciting, clinically relevant new research in Blood Neoplasia.”

Keith McCrae, MD
Editor-in-Chief of Blood VTH
Cleveland Clinic Taussig Cancer Institute

“Blood Vessels, Thrombosis & Hemostasis provides a new venue for hematologists engaged in clinical care and research in thrombosis and hemostasis to bring forward top quality clinical, translational, and basic science to the Blood journals.”

ASH Clinical News

In 2023, ASH Clinical News continued to thrive and advance under the leadership of Editor-in-Chief Aaron T. Gerds, MD, MS. In addition to releasing 15 issues throughout the year and reporting on the ASH annual meeting, the publication introduced a series of webinars for members to participate in and learn from discussions with key speakers. ASH Clinical News received three editorial awards in 2023.
Learn more

Blood

Blood continued its long reign as hematology’s top journal for research. The journal achieved an impact factor 20.3, an h5-index of 158, and an Eigenfactor of 0.15346, with 180,276 citations in 2023.
Learn more

Blood Advances

ASH’s first open access journal continued to grow in 2023. It published more peer-reviewed hematology research articles than any other journal worldwide, with 824 articles in 2023. Blood Advances achieved an impact factor 7.6, an h5-index of 86, and an Eigenfactor of 0.05301, with 16,941 citations in 2023.
Learn more

Blood Neoplasia

Blood Neoplasia is an open access journal publishing research focused on hematologic malignancies and associated disorders, including leukemia, lymphoma, multiple myeloma, and more. Jonathan Licht, MD, was named its inaugural editor-in-chief. Its first articles will publish in 2024.
Learn more

Blood Vessels, Thrombosis, & Hemostasis (VTH)

Blood VTH is an open access journal focusing on thrombosis, hemostasis, and vascular biology, as well as associated disorders, including hemorrhagic disorders and blood platelet disorders. Keith McCrae, MD, was named its inaugural editor-in-chief. Its first articles will publish in 2024.
Learn more

The Hematologist

Editor-in-Chief Shaji Kumar, MD, took the helm of The Hematologist in 2023 and introduced several new features, including “Not So Benign” articles that spotlight classical hematologic disorders that can cause suffering for those affected, and “Technology Spotlight” articles, which highlight new technology being used in hematology.
Learn more

Hematology Education Program

This invaluable textbook contains review articles from the education program at the 2023 ASH Annual Meeting. Each chapter relates to a different session at the annual meeting, from basic discovery to clinical application. The digital version is free for ASH members and annual meeting attendees; a print version is available for purchase.
 

Image Bank

A comprehensive collection of images relating to a wide range of hematologic topics, the ASH Image Bank allows users to discover high-quality, peer-reviewed hematologic images.

Explore the 2023 Annual Report